Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 19/20 | 0.54 |
| ▸ | CNR2 | P34972 | 19/20 | 0.54 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL768406 | 0.88 | NR5A1 (0.47) | CNR1CNR2NR5A1 | |
| SCHEMBL9652029 | 0.86 | CA1 (0.53) | CNR1CNR2 | |
| SCHEMBL1086609 | 0.85 | CA1 (0.52) | CNR1CNR2NR5A1 | |
| SCHEMBL9999756 | 0.85 | CA1 (0.52) | CNR1CNR2NR5A1 | |
| SCHEMBL6693439 | 0.85 | CA1 (0.52) | CNR1CNR2NR5A1 | |
| SCHEMBL11782759 | 0.84 | NR5A1 (0.51) | CNR1CNR2NR5A1 | |
| SCHEMBL10885993 | 0.82 | CNR1 (0.45) | CNR1CNR2 | |
| SCHEMBL1836097 | 0.80 | CNR2 (0.55) | CNR1CNR2 | |
| SCHEMBL1839235 | 0.80 | CNR2 (0.55) | CNR1CNR2 | |
| SCHEMBL1836711 | 0.80 | CNR2 (0.55) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8344175-B2 | Liquid crystal compositions, polymer networks derived therefrom and process for making the same | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-01 | — | — | US | disclosed |
| US-8334393-B2 | Chiral compounds and liquid crystal compositions and polymer networks derived therefrom | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-18 | — | — | US | disclosed |
| EP-2440632-A2 | LIQUID CRYSTAL COMPOSITIONS | E. I. du Pont de Nemours and Company (US) | 2012-04-18 | — | — | EP | disclosed |
| US-20120071618-A1 | LIQUID CRYSTAL COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-22 | — | — | US | disclosed |
| US-8067068-B2 | Liquid crystal compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-29 | — | — | US | disclosed |
| US-8044228-B2 | Liquid crystal compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-10-25 | — | — | US | disclosed |
| US-20110163267-A1 | CHIRAL COMPOUNDS AND LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-07-07 | — | — | US | disclosed |
| US-20110114885-A1 | LIQUID CRYSTAL COMPOSITIONS, POLYMER NETWORKS DERIVED THEREFROM AND PROCESS FOR MAKING THE SAME | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-05-19 | — | — | US | disclosed |
| EP-2001974-B1 | LIQUID CRYSTAL COMPOSITIONS, POLYMER NETWORKS DERIVED THEREFROM AND PROCESS FOR MAKING THE SAME | DU PONT (US) | 2011-03-30 | — | — | EP | disclosed |
| US-7914700-B2 | Liquid crystal compositions and polymer networks derived therefrom | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-03-29 | — | — | US | disclosed |
| US-7339007-B2 | Low sediment process for thermally reacting highly reactive polymers and enophiles | INFINEUM INTERNATIONAL LIMITED (GB) | 2008-03-04 | — | — | US | disclosed |
| US-20070267599-A1 | Liquid crystal compositions and polymer networks derived therefrom | GOLDFINGER MARC B | 2007-11-22 | — | — | US | disclosed |
| WO-2007120459-A2 | CHIRAL DIOLE COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-10-25 | — | — | WO | disclosed |
| WO-2007120458-A1 | LIQUID CRYSTAL COMPOSITIONS, POLYMER NETWORKS DERIVED THEREFROM AND PROCESS FOR MAKING THE SAME | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-10-25 | — | — | WO | disclosed |
| US-20070228326-A1 | Liquid crystal compositions, polymer networks derived therefrom and process for making the same | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-10-04 | — | — | US | disclosed |
| US-6933351-B2 | Process for forming polyalkenyl acylating agents | INFINEUM INTERNATIONAL LIMITED (GB) | 2005-08-23 | — | — | US | disclosed |
| US-20040260032-A1 | Low sediment process for thermally reacting highly reactive polymers and enophiles | INFINEUM INTERNATIONAL LIMITED (GB) | 2004-12-23 | — | — | US | disclosed |
| US-20040260027-A1 | Process for forming polyalkenyl acylating agents | INFINEUM INTERNATIONAL LIMITED (GB) | 2004-12-23 | — | — | US | disclosed |
| EP-1489105-A2 | Process for thermally reacting highly reactive polymers and enophiles | Infineum International Limited (GB) | 2004-12-22 | — | — | EP | disclosed |
| EP-1489107-A2 | Process for forming polyalkenylacylating agents, lubricating oil and additive for a lubricating oil | Infineum International Limited (GB) | 2004-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070267599-A1 | Liquid crystal compositions and polymer networks derived therefrom | F2, CCNB1, CYP2F1 | CNR1 94/4885CNR2 126/4885NR5A1 403/4885 |
| US-20110163267-A1 | CHIRAL COMPOUNDS AND LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM | CCNB1, F2, CYP4F11 | CNR1 196/4885CNR2 295/4885NR5A1 505/4885 |
| US-20120071618-A1 | LIQUID CRYSTAL COMPOSITIONS | CNOT9, AQP3, AQP1 | CNR1 2878/4885CNR2 2378/4885NR5A1 2523/4885 |
| US-20110114885-A1 | LIQUID CRYSTAL COMPOSITIONS, POLYMER NETWORKS DERIVED THEREFROM AND PROCESS FOR MAKING THE SAME | THEM6, NOTUM, WEE1 | CNR1 2538/4885CNR2 2253/4885NR5A1 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.